NSCI — Nanalysis Scientific Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Nanalysis Scientific, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	6.62	3.16	10.4	3.52	0.759
Net Total Accounts Receivable
Net Total Receivables	2.56	3.04	6.1	8.98	9.76
Total Inventory
Prepaid Expenses
Total Current Assets	10.2	9.35	20.8	22	17.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.63	1.95	2.54	6.42	4.74
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	18.3	24	37.8	69.9	53.8
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.63	6.3	8.65	13.5	14.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3.19	9.64	13.8	34.8	30.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	15.1	14.3	24	35.1	23.5
Total Liabilities & Shareholders' Equity	18.3	24	37.8	69.9	53.8
Total Common Shares Outstanding